ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오마커 검사 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 12.5%로 성장할 전망이며, 316억 3,000만 달러로 성장이 예측됩니다. 예측 기간 성장의 배경에는 암 이외 질환에서 바이오마커 적용 확대, 동반진단에 대한 투자 증가, 진단 프로세스에 대한 인공지능 통합 진전, 포인트 오브 케어 검사 채택 확대, 예방 헬스케어에 대한 인식 제고 등이 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 시퀀싱 기술의 발전, 리퀴드 바이옵시에서 기술 혁신의 진전, 멀티플렉스 바이오마커 플랫폼의 진보, 프로테오믹스 및 메타볼로믹스에서의 돌파, 연구개발 투자 증가 등을 들 수 있습니다.
암 부담 증가는 향후 수년간 바이오마커 검사 시장의 성장을 가속할 것으로 예측됩니다. 암은 비정상적인 세포의 제어 불가능한 증식과 확산으로 특징지어지는 질환군입니다. 이러한 부담의 증가는 건강하지 못한 식생활, 흡연, 운동 부족, 과도한 알코올 섭취 등 라이프 스타일과 관련된 위험 인자에 크게 기인하고 있습니다. 바이오마커 검사는 질환 특이적 마커의 조기 정확한 동정을 가능하게 함으로써 진단 정확도를 향상시키고 암 발견에 중요한 역할을 합니다. 또한 개별화된 치료 전략을 촉진하고 환자의 회귀를 개선하여 보다 효율적인 헬스케어 관리를 실현합니다. 예를 들어 2024년 7월 호주 보건복지랩은 2022년 호주에서 165,70건의 암이 진단돼 2021년 15만 6,781건에서 3,789건이 증가했다고 보고했습니다. 따라서 암의 이환율 증가가 바이오마커 검사 시장 확대에 크게 기여하고 있습니다.
바이오마커 검사 시장에서 사업을 전개하는 주요 기업은 진단 정밀도를 높이고, 질병의 조기 발견을 가능하게 하며, 맞춤형 치료 전략을 지원하기 위해 면역조직화학(IHC) 기술 등의 기술적으로 선진적인 솔루션 개발에 주력하고 있습니다. 면역조직화학(IHC)은 항체를 이용하여 조직 샘플 중의 특정 단백질을 검출하는 검사 기술이며, 질병의 진단이나 연구에 필수적인 바이오마커의 동정 및 가시화를 가능하게 합니다. 예를 들면, 미국을 거점으로 하는 의료 검사 회사 퀘스트 다이애그노스틱스 인코퍼레이티드는, 2023년 7월, AmeriPath 사업을 통해서 새로운 조직 기반의 전립선암 바이오 마커 검사를 개시했습니다. 이 검사는 자체 바이오마커인 EV1, EV2, EV3를 활용해 의사들이 보다 정확하게 진행성 전립선암을 동정 및 식별할 수 있도록 함으로써 진단 정확도를 향상시키고 있습니다. 이 검사는 진단의 일관성을 높이고 적절한 개별화 치료 전략을 유도함으로써 임상상의 중요한 요구에 부응하는 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 바이오마커 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 바이오마커 검사 시장 : 성장률 분석
세계의 바이오마커 검사 시장 실적 : 규모 및 성장(2019-2024년)
세계의 바이오마커 검사 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 바이오마커 검사 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 바이오마커 검사 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
소모품
장치
서비스
세계의 바이오마커 검사 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
중합효소 연쇄반응
차세대 시퀀싱
면역 측정
기타
세계의 바이오마커 검사 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
종양학
심장병학
신경학
감염증
기타
세계의 바이오마커 검사 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
진단 실험실
연구기관
기타
세계의 바이오마커 검사 시장 : 소모품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
시약
분석 키트
샘플 수집 장치
화학제품 및 완충제
세계의 바이오마커 검사 시장 : 장치별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
중합효소 연쇄반응(PCR) 시스템
차세대 시퀀싱(NGS) 플랫폼
마이크로어레이 시스템
질량 분석 장치
면역 측정 분석 장치
세계의 바이오마커 검사 시장 : 서비스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
바이오마커 탐색 서비스
진단 검사 서비스
동반진단 개발
임상 검사 서비스
계약연구기관(CRO)서비스
제7장 지역별 및 국가별 분석
세계의 바이오마커 검사 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 바이오마커 검사 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
바이오마커 검사 시장 : 경쟁 구도
바이오마커 검사 시장 : 기업 프로파일
Roche Diagnostics International Ltd.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Danaher Corporation
Merck KGaA
제31장 기타 주요 기업 및 혁신 기업
Siemens Healthineers AG
Becton Dickinson and Company
GE HealthCare Technologies Inc.
Agilent Technologies Inc.
Illumina Inc.
Hologic Inc.
Charles River Laboratories International Inc.
PerkinElmer Inc.
Sysmex Corporation
Bio-Rad Laboratories Inc.
DiaSorin SpA
Myriad Genetics Inc.
Guardant Health Inc.
Sino Biological Inc.
Proteome Sciences plc
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
바이오마커 검사 시장(2029년) : 새로운 기회를 제공하는 국가
바이오마커 검사 시장(2029년) : 새로운 기회를 제공하는 부문
바이오마커 검사 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Biomarker testing involves examining blood, tissue, or other bodily fluids to detect specific biological indicators that signify either normal or pathological conditions. This process is vital for disease diagnosis, monitoring disease progression, and creating personalized treatment strategies.
Biomarker testing includes several product types such as consumables, instruments, services, and more. Consumables refer to items that are used and depleted during procedures and must be replenished regularly, including medical supplies, food items, or office essentials. The primary technologies employed are polymerase chain reaction (PCR), next-generation sequencing (NGS), immunoassays, among others. It is widely used in fields such as oncology, cardiology, neurology, and infectious diseases, with key end-users including hospitals, diagnostic labs, research institutions, and other healthcare settings.
The biomarker testing market research report is one of a series of new reports from The Business Research Company that provides biomarker testing market statistics, including the biomarker testing industry global market size, regional shares, competitors with the biomarker testing market share, detailed biomarker testing market segments, market trends, and opportunities, and any further data you may need to thrive in the biomarker testing industry. These biomarker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The biomarker testing market size has grown rapidly in recent years. It will grow from $17.51 billion in 2024 to $19.75 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth during the historic period can be attributed to the rising adoption of personalized medicine, the increased utilization of biomarkers in oncology, the growing prevalence of chronic illnesses, expanded research funding in the life sciences sector, and the heightened demand for early disease detection.
The biomarker testing market size is expected to see rapid growth in the next few years. It will grow to $31.63 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to the expanding application of biomarkers in non-oncology conditions, increasing investments in companion diagnostics, greater integration of artificial intelligence into diagnostic processes, the rising adoption of point-of-care testing, and growing awareness of preventive healthcare. Key trends expected during the forecast period include advancements in sequencing technologies, ongoing innovations in liquid biopsy, progress in multiplex biomarker platforms, breakthroughs in proteomics and metabolomics, and rising investments in research and development.
The rising cancer burden is expected to drive the growth of the biomarker testing market in the coming years. Cancer comprises a group of diseases marked by the uncontrolled growth and spread of abnormal cells. This increasing burden is largely attributed to lifestyle-related risk factors such as unhealthy diets, smoking, physical inactivity, and excessive alcohol consumption. Biomarker testing plays a vital role in cancer detection by enabling early and accurate identification of disease-specific markers, thereby improving diagnostic precision. It also facilitates personalized treatment strategies, resulting in improved patient outcomes and more efficient healthcare management. For instance, in July 2024, the Australian Institute of Health and Welfare reported that 160,570 cancer cases were diagnosed in Australia in 2022, an increase of 3,789 cases from 156,781 in 2021. Therefore, the growing incidence of cancer is contributing significantly to the expansion of the biomarker testing market.
Major companies operating in the biomarker testing market are focusing on developing technologically advanced solutions, such as immunohistochemistry (IHC) technology, to enhance diagnostic accuracy, enable early disease detection, and support personalized treatment strategies. Immunohistochemistry (IHC) is a laboratory technique that utilizes antibodies to detect specific proteins in tissue samples, enabling the identification and visualization of biomarkers critical for disease diagnosis and research. For example, in July 2023, Quest Diagnostics Incorporated, a U.S.-based medical laboratory company, launched a new tissue-based prostate cancer biomarker test through its AmeriPath business. This test leverages proprietary biomarkers EV1, EV2, and EV3 to improve diagnostic precision by helping physicians more accurately identify and distinguish aggressive prostate cancer types. It addresses a critical clinical need by enhancing grading consistency and guiding appropriate, individualized treatment strategies.
In August 2025, Quanterix Corp., a U.S.-based life sciences company, acquired Emission Inc. for approximately $70 million. This acquisition is aimed at expanding Quanterix's technology portfolio and market presence by incorporating Emission's advanced multiplex and multi-omic assay technologies. The integration is expected to strengthen Quanterix's position in the biomarker testing sector, enhance its diagnostic capabilities, and open new market opportunities. Emission Inc. is a U.S.-based biotechnology company specializing in multiplex and multi-omic assay solutions for biomarker testing.
Major players in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc
North America was the largest region in the biomarker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biomarker testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biomarker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biomarker testing market consists of revenues earned by entities by providing services such as clinical biomarker testing services, bioinformatics and data analysis services, sample collection and biobanking services, and companion diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The biomarker testing market includes sales of analytical instruments, imaging devices, lab-on-a-chip and microfluidic devices, and data acquisition and integration hardware. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biomarker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biomarker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biomarker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomarker testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Consumables; Instruments; Services
2) By Technology: Polymerase Chain Reaction; Next-Generation Sequencing; Immunoassays; Other Technologies
3) By Application: Oncology; Cardiology; Neurology; Infectious Diseases; Other Applications
4) By End-User: Hospitals; Diagnostic Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Consumables: Reagents; Assay Kits; Sample Collection Devices; Chemicals And Buffers
2) By Instruments: Polymerase Chain Reaction (PCR) Systems; Next-Generation Sequencing (NGS) Platforms; Microarray Systems; Mass Spectrometry Instruments; Immunoassay Analyzers
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biomarker Testing Market Characteristics
3. Biomarker Testing Market Trends And Strategies
4. Biomarker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Biomarker Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Biomarker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Biomarker Testing Market Growth Rate Analysis
5.4. Global Biomarker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Biomarker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Biomarker Testing Total Addressable Market (TAM)
6. Biomarker Testing Market Segmentation
6.1. Global Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Instruments
Services
6.2. Global Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction
Next-Generation Sequencing
Immunoassays
Other Technologies
6.3. Global Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiology
Neurology
Infectious Diseases
Other Applications
6.4. Global Biomarker Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Research Institutes
Other End-Users
6.5. Global Biomarker Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents
Assay Kits
Sample Collection Devices
Chemicals And Buffers
6.6. Global Biomarker Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR) Systems
Next-Generation Sequencing (NGS) Platforms
Microarray Systems
Mass Spectrometry Instruments
Immunoassay Analyzers
6.7. Global Biomarker Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biomarker Discovery Services
Diagnostic Testing Services
Companion Diagnostic Development
Clinical Trial Testing Services
Contract Research Organization (CRO) Services
7. Biomarker Testing Market Regional And Country Analysis
7.1. Global Biomarker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Biomarker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
